fructose-1,6-diphosphate has been researched along with Ventricular Dysfunction, Left in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atluri, P; Berry, MF; Cohen, JE; Gardner, TJ; Grand, TJ; Hsu, VM; Liao, GP; Panlilio, CM; Smith, MJ; Suarez, EE; Sweeney, HL; Taylor, MD; Woo, YJ; Zentko, SE | 1 |
| Brumley, MA; Figueroa, A; Lehan, PH; Markov, AK; Skelton, TN | 1 |
2 other study(ies) available for fructose-1,6-diphosphate and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Cardiovascular Agents; Fructosediphosphates; Glycolysis; Injections, Intravenous; Male; Models, Animal; Myocardial Ischemia; Myocardial Reperfusion Injury; Phosphofructokinase-1; Rats; Rats, Wistar; Ventricular Dysfunction, Left | 2006 |
Hemodynamic effects of fructose 1,6-diphosphate in patients with normal and impaired left ventricular function.
Topics: Cardiac Catheterization; Case-Control Studies; Coronary Disease; Energy Metabolism; Female; Fructosediphosphates; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardium; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 1997 |